HDL-C and Apo-AI levels increased from baseline over the same time period, but did not reach statistical significance ( Figures 1 and 3 ).
← all excerpts
Efficacy and safety of atorvastatin in South Asian patients with dyslipidemia: an open label noncomparative pilot study.
1
—
—